FG
ABBV icon

Fiduciary Group’s AbbVie ABBV Stock Holding History

Fiduciary Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.12M Sell
23,561
-62
-0.3% -$13.8K 0.44% 61
2025
Q4 		$5.4M Sell
23,623
-697
-3% -$159K 0.45% 57
2025
Q3 		$5.63M Buy
24,320
+232
+1% +$47.2K 0.49% 53
2025
Q2 		$4.47M Sell
24,088
-294
-1% -$54.6K 0.42% 59
2025
Q1 		$5.11M Buy
24,382
+487
+2% +$94.7K 0.51% 52
2024
Q4 		$4.25M Sell
23,895
-292
-1% -$53.7K 0.43% 60
2024
Q3 		$4.78M Buy
24,187
+19
+0.1% +$3.55K 0.48% 55
2024
Q2 		$4.15M Sell
24,168
-286
-1% -$47.4K 0.45% 60
2024
Q1 		$4.45M Sell
24,454
-241
-1% -$41.5K 0.49% 56
2023
Q4 		$3.83M Sell
24,695
-120
-0.5% -$17.5K 0.45% 63
2023
Q3 		$3.7M Sell
24,815
-19
-0.1% -$2.79K 0.47% 58
2023
Q2 		$3.35M Sell
24,834
-235
-0.9% -$34.5K 0.41% 63
2023
Q1 		$4M Buy
25,069
+667
+3% +$102K 0.52% 54
2022
Q4 		$3.94M Sell
24,402
-88
-0.4% -$13.5K 0.53% 52
2022
Q3 		$3.67M Buy
24,490
+369
+2% +$53K 0.48% 59
2022
Q2 		$3.43M Buy
24,121
+382
+2% +$58.4K 0.43% 63
2022
Q1 		$3.61M Sell
23,739
-7
-0% -$1.02K 0.48% 57
2021
Q4 		$3.21M Sell
23,746
-122
-0.5% -$14.4K 0.36% 64
2021
Q3 		$2.61M Sell
23,868
-1,063
-4% -$121K 0.3% 70
2021
Q2 		$2.87M Buy
24,931
+221
+0.9% +$24.9K 0.33% 66
2021
Q1 		$2.75M Buy
24,710
+200
+0.8% +$21.4K 0.34% 65
2020
Q4 		$2.54M Sell
24,510
-850
-3% -$81.7K 0.34% 64
2020
Q3 		$2.22M Buy
25,360
+50
+0.2% +$4.71K 0.34% 65
2020
Q2 		$2.48M Sell
25,310
-200
-0.8% -$17.6K 0.41% 52
2020
Q1 		$1.94M Sell
25,510
-427
-2% -$36.4K 0.38% 56
2019
Q4 		$2.3M Sell
25,937
-1,158
-4% -$96.1K 0.37% 59
2019
Q3 		$2.05M Sell
27,095
-10,773
-28% -$739K 0.36% 62
2019
Q2 		$2.75M Sell
37,868
-8,179
-18% -$643K 0.49% 52
2019
Q1 		$3.71M Sell
46,047
-972
-2% -$79.5K 0.69% 44
2018
Q4 		$4.33M Sell
47,019
-2,471
-5% -$217K 0.9% 37
2018
Q3 		$4.68M Sell
49,490
-5,839
-11% -$554K 0.92% 33
2018
Q2 		$5.13M Sell
55,329
-2,053
-4% -$201K 1.08% 30
2018
Q1 		$5.43M Sell
57,382
-1,410
-2% -$155K 1.18% 28
2017
Q4 		$5.69M Sell
58,792
-2,716
-4% -$256K 1.21% 30
2017
Q3 		$5.47M Sell
61,508
-5,745
-9% -$437K 1.23% 29
2017
Q2 		$4.88M Sell
67,253
-2,420
-3% -$163K 1.13% 30
2017
Q1 		$4.54M Buy
69,673
+1,531
+2% +$96.3K 1.08% 31
2016
Q4 		$4.27M Sell
68,142
-817
-1% -$49.9K 1.1% 28
2016
Q3 		$4.35M Sell
68,959
-219
-0.3% -$14.2K 1.18% 28
2016
Q2 		$4.28M Sell
69,178
-894
-1% -$54.5K 1.19% 26
2016
Q1 		$4M Sell
70,072
-4,797
-6% -$267K 1.16% 30
2015
Q4 		$4.43M Buy
74,869
+911
+1% +$52.5K 1.32% 25
2015
Q3 		$4.02M Buy
73,958
+480
+0.7% +$31.2K 1.34% 21
2015
Q2 		$4.94M Buy
+73,478
New +$4.8M 1.55% 15

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fiduciary Group's ABBV Position: Q1 2026 in Review

Fiduciary Group reduced its AbbVie (ABBV) stake by 0.26% in Q1 2026, selling an estimated $13.8K and leaving 23,561 shares worth $5.12M. The position accounts for 0.44% of the portfolio, ranked #61.

Fiduciary Group first reported a position in ABBV in Q2 2015 and has held it in 44 quarters since. The position peaked at $5.69M in Q4 2017. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Fiduciary Group held 23,561 shares of AbbVie worth $5.12M as of Q1 2026.
  • Fiduciary Group sold 62 AbbVie shares in Q1 2026, an estimated $13.8K.
  • AbbVie made up 0.44% of Fiduciary Group's portfolio in Q1 2026, its #61 holding.
  • Fiduciary Group first reported a position in AbbVie in Q2 2015 and has held it in 44 quarters since.
  • Fiduciary Group's AbbVie position peaked at $5.69M in Q4 2017.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Fiduciary Group's 13F filing for Q1 2026, filed 11 May 2026.